Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cardiff Oncology Inc. buy melinda

Start price
€3.84
05.04.19 / 50%
Target price
€7.00
04.11.21
Performance (%)
29.61%
End price
€4.98
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €4.98. The prediction had a final performance of 29.61%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Cardiff Oncology Inc. 14.725% 14.725% 283.260% -38.225%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by melinda for this prediction

In the thread Trovagene diskutieren
Prediction Buy
Perf. (%) 29.61%
Target price 7.216
Change
Ends at 04.11.21

Biopharma



* TrovaGene gibt Vereinbarung mit einem globalen biopharmazeutischen Unternehmen , die Tests und Dienstleistungen zu verwenden trova® ctDNS in der klinischen Krebsstudien



Kursziel geändert auf 7,0

In the thread Trading Trovagene
Prediction Buy
Perf. (%) 29.61%
Target price 7.000
Change
Ends at 04.11.21

Die von melinda gewählte maximale Laufzeit wurde überschritten

Stopped prediction by melinda for Cardiff Oncology Inc.

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.61
18.01.23
€2.00
18.01.24
-16.30%
19.01.24

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€76.61
22.06.17
€108.00
19.12.17
-82.61%
19.12.17

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€76.61
22.06.17
€108.00
19.12.17
-82.61%
19.12.17

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€271.44
05.05.16
€324.00
19.05.16
31.03%
19.05.16